ICT Ventures Bangladesh

ICT Ventures Bangladesh is a Dhaka-based technology-focused investor fostering early-stage digital health and information technology solutions in the local ecosystem. Stage focus is seed and Series A with checks in the $250k to $1M range, and AI is not flagged as a primary focus. The fund occupies a relatively rare position in Bangladesh’s underbuilt early-stage venture stack, where institutional capital remains scarce and a local fund with structured investment processes is materially differentiated. The right founder for ICT Ventures Bangladesh is a Bangladeshi operator, often returnees from international careers or experienced local operators, building a digital health, telehealth, healthcare software, or healthcare information technology business with credible Bangladesh-market wedge. The wrong founder is a deep medtech or therapeutics team, a non-Bangladesh founder using Dhaka as a satellite, or a Series A-plus company looking for institutional lead at scale. Intro paths run through Dhaka’s growing venture community including Startup Bangladesh, the iDEA Project, BRAC’s social enterprise networks, and frequent co-investors and follow-on partners including BD Ventures, Anchorless Bangladesh, Osiris Group, IFC, and regional South Asian funds that occasionally look at Bangladeshi deals. Direct outreach is read but warm intros from local operators or program affiliations materially help. In the pitch, lead with the founding team’s depth in Bangladesh’s healthcare system, the unit economics in BDT with realistic CAC assumptions and a candid view of payment rails and conversion friction, and a credible plan for navigating Bangladesh’s healthcare regulatory environment including the Directorate General of Drug Administration and the Ministry of Health and Family Welfare. Show that you understand the dual-economy reality where private out-of-pocket health spending dominates and public-sector capacity is overstretched. Be specific about how you will deal with FX volatility and capital flow friction, both of which complicate dollar-denominated investor returns from Bangladeshi-incorporated entities. Caveats are real and structural. Bangladesh has limited follow-on capital, FX and capital flow friction can complicate dollar-denominated investor returns, and many Bangladeshi entrepreneurs eventually need to redomicile their holding company in Singapore or Delaware to ease global capital raising; founders should think about this structure early. For early-stage Bangladeshi healthcare entrepreneurs, ICT Ventures Bangladesh is a useful local capital partner that requires parallel international syndicate construction.